Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein C pseudogene 2 (HNRNPCP2) is a genomic sequence classified as a pseudogene; it shares sequence similarity with heterogeneous nuclear ribonucleoprotein C genes but does not encode a functional protein. Pseudogenes like HNRNPCP2 are typically remnants of duplicated or otherwise inactivated genes and are not considered biologically active. There is no evidence in current literature or major gene databases that HNRNPCP2 is involved in disease, acts as a therapeutic target, or displays any biological functions apart from sequence homology to its parent gene family[1]. This entry reflects the distinction that HNRNPCP2 is not a functional target—and is thus not suitable for inclusion in structured drug or receptor databases. If the intended target is HNRNPC (the functional protein), it is recommended to use "heterogeneous nuclear ribonucleoprotein C (HNRNPC)" instead[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein C pseudogene 2 (HNRNPCP2).